Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allergy to Grass Pollen”

109 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 109 results

Testing effectiveness (Phase 2)Study completedNCT02556801
What this trial is testing

Efficacy and Safety of SUBLIVAC Phleum for Immunotherapy of Grass Pollen-Allergy

Who this might be right for
Allergic RhinitisAllergic Rhinoconjunctivitis
HAL Allergy 168
Not applicableStudy completedNCT03315611
What this trial is testing

Study to Assess the Effect of "Eucerin AtopiControl" on Dermal Symptoms in Patients With Atopic Dermatitis

Who this might be right for
Atopic DermatitisAllergy Pollen
Fraunhofer-Institute of Toxicology and Experimental Medicine 23
Testing effectiveness (Phase 2)Study completedNCT01448902
What this trial is testing

The Effects Of OC000459 In Subjects Known To Suffer From Grass Pollen Induced Allergic Rhinitis

Who this might be right for
Allergic Rhinitis
Oxagen Ltd 36
Testing effectiveness (Phase 2)Study completedNCT01445002
What this trial is testing

Safety and Dose Finding Trial of BM32 in Subjects Suffering From Grass Pollen Allergy

Who this might be right for
Grass Pollen Allergy
Biomay AG 79
Testing effectiveness (Phase 2)Study completedNCT00862225
What this trial is testing

MOA Study of Ze 339 in Seasonal Allergic Rhinitis

Who this might be right for
Seasonal Allergic Rhinitis
Max Zeller Soehne AG 18
Not applicableStudy completedNCT01085526
What this trial is testing

Changes in Specific Immunoglobulin and Blood Basophil Activity During Subcutaneous Immunotherapy in Allergic Rhinitis

Who this might be right for
Allergic Rhinoconjunctivitis
Aarhus University Hospital 30
Post-approval studies (Phase 4)Study completedNCT00542607
What this trial is testing

Efficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic Rhinitis

Who this might be right for
Rhinitis, Allergic, Seasonal
UCB Pharma 94
Post-approval studies (Phase 4)Study completedNCT00150514
What this trial is testing

Effects of Sublingual Immunotherapy on Grasspollen Allergy

Who this might be right for
Hayfever
Radboud University Medical Center 38
Testing effectiveness (Phase 2)Study completedNCT02643641
What this trial is testing

Effect of Different Pre-seasonal BM32 Dosings on the Induction of a Protective Immune Response

Who this might be right for
Hypersensitivity
Biomay AG 130
Early research (Phase 1)Study completedNCT03931993
What this trial is testing

Tolerability and Safety of a New Cumulative Dose of Grass MATA MPL

Who this might be right for
Seasonal Allergic Rhinitis
Allergy Therapeutics 30
Large-scale testing (Phase 3)UnknownNCT03724240
What this trial is testing

Clinical Efficacy and Safety of Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis

Who this might be right for
Hay Fever
ASIT Biotech S.A. 624
Testing effectiveness (Phase 2)Study completedNCT00666341
What this trial is testing

Dose-Response-Study With a Recombinant Cocktail of Phleum (rPhleum) Allergens

Who this might be right for
Type I-Allergy
Allergopharma GmbH & Co. KG 50
Testing effectiveness (Phase 2)Study completedNCT01506375
What this trial is testing

Safety of gpASIT+TM Subcutaneously Administered to Hay Fever Patients With or Without Immunoregulating Adjuvant

Who this might be right for
Hay Fever
BioTech Tools S.A. 24
Testing effectiveness (Phase 2)Study completedNCT00833066
What this trial is testing

Safety Study of Grass Pollen-derived Peptides to Treat Seasonal Allergic Rhinoconjunctivitis

Who this might be right for
Seasonal Allergic Rhinoconjunctivitis
BioTech Tools S.A. 54
Large-scale testing (Phase 3)Study completedNCT00567346
What this trial is testing

Efficacy and Safety of Grass Pollen Sublingual Immunotherapy

Who this might be right for
Allergic Rhinoconjunctivitis
Artu Biologicals 605
Large-scale testing (Phase 3)Study completedNCT05191186
What this trial is testing

Documentation of Efficacy of Intralymphatic Allergen Immunotherapy

Who this might be right for
Allergic Rhinitis Due to Grass PollenAllergic Conjunctivitis of Both EyesAllergic Asthma
Aarhus University Hospital 450
Large-scale testing (Phase 3)Study completedNCT00773240
What this trial is testing

A Phase III Trial Assessing the Pharmacodynamic Effect and the Tolerability of Grazax Treatment

Who this might be right for
Grass Pollen Allergy
ALK-Abelló A/S 276
Large-scale testing (Phase 3)Study completedNCT00916422
What this trial is testing

Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Grass Pollen

Who this might be right for
Seasonal Allergic Rhinitis
Laboratorios Leti, S.L. 153
Post-approval studies (Phase 4)Study completedNCT00698594
What this trial is testing

Comparison of Effectiveness and Safety of Sublingual Immunotherapy in Children With Allergic Rhinitis

Who this might be right for
Allergic Rhinitis
Medical University of Lodz 60
Not applicableStudy completedNCT00461721
What this trial is testing

Pilot Trial to Elaborate a Cutaneous Antigen Neutralization Test in Patients Suffering From Rhinoconjunctivitis

Who this might be right for
Allergy
University of Zurich 20
Load More Results